GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avecho Biotechnology Ltd (OTCPK:AVEFF) » Definitions » Net Margin %

AVEFF (Avecho Biotechnology) Net Margin % : -115.16% (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Avecho Biotechnology Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Avecho Biotechnology's Net Income for the six months ended in Dec. 2024 was $-0.60 Mil. Avecho Biotechnology's Revenue for the six months ended in Dec. 2024 was $0.52 Mil. Therefore, Avecho Biotechnology's net margin for the quarter that ended in Dec. 2024 was -115.16%.

The historical rank and industry rank for Avecho Biotechnology's Net Margin % or its related term are showing as below:

AVEFF' s Net Margin % Range Over the Past 10 Years
Min: -1090.3   Med: -557.33   Max: 20.06
Current: -241.27


AVEFF's Net Margin % is ranked worse than
57.14% of 1008 companies
in the Biotechnology industry
Industry Median: -134.65 vs AVEFF: -241.27

Avecho Biotechnology Net Margin % Historical Data

The historical data trend for Avecho Biotechnology's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avecho Biotechnology Net Margin % Chart

Avecho Biotechnology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -684.14 -430.11 -194.10 -725.87 -241.10

Avecho Biotechnology Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -349.67 -477.59 -4,866.67 -461.34 -115.16

Competitive Comparison of Avecho Biotechnology's Net Margin %

For the Biotechnology subindustry, Avecho Biotechnology's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avecho Biotechnology's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avecho Biotechnology's Net Margin % distribution charts can be found below:

* The bar in red indicates where Avecho Biotechnology's Net Margin % falls into.



Avecho Biotechnology Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Avecho Biotechnology's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-1.977/0.82
=-241.10 %

Avecho Biotechnology's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-0.6/0.521
=-115.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avecho Biotechnology  (OTCPK:AVEFF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Avecho Biotechnology Net Margin % Related Terms

Thank you for viewing the detailed overview of Avecho Biotechnology's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Avecho Biotechnology Business Description

Traded in Other Exchanges
Address
Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skincare and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

Avecho Biotechnology Headlines